These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9354833)

  • 21. Hemolytic transfusion reaction after preoperative prophylactic blood transfusion for sickle cell disease in pregnancy.
    Proudfit CL; Atta E; Doyle NM
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):471-4. PubMed ID: 17666632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis.
    Diamond WJ; Brown FL; Bitterman P; Klein HG; Davey RJ; Winslow RM
    Ann Intern Med; 1980 Aug; 93(2):231-4. PubMed ID: 7406372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Delayed hemolytic reaction to transfusion in sickle cell anemia. Report of one case].
    Moya F; Rivera M; Araya F; Donoso J; Sandoval P; Varas P
    Rev Med Chil; 2018 Nov; 146(11):1347-1350. PubMed ID: 30725050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases.
    Santos B; Portugal R; Nogueira C; Loureiro M
    Transfusion; 2015 Jun; 55(6 Pt 2):1394-8. PubMed ID: 25677578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease.
    Chonat S; Quarmyne MO; Bennett CM; Dean CL; Joiner CH; Fasano RM; Stowell SR
    Haematologica; 2018 Oct; 103(10):e483-e485. PubMed ID: 29794144
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of post-transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti-IL6R humanised monoclonal antibody Tocilizumab.
    Sivapalaratnam S; Linpower L; Sirigireddy B; Agapidou A; Jain S; Win N; Tsitsikas DA
    Br J Haematol; 2019 Sep; 186(6):e212-e214. PubMed ID: 31368112
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease.
    Floch A; Morel A; Zanchetta-Balint F; Cordonnier-Jourdin C; Allali S; Grall M; Ithier G; Carpentier B; Pakdaman S; Merle JC; Goulabchand R; Khalifeh T; Berceanu A; Helmer C; Chantalat-Auger C; Frémeaux-Bacchi V; Michel M; de Montalembert M; Mekontso-Dessap A; Pirenne F; Habibi A; Bartolucci P
    Haematologica; 2020 Nov; 105(11):2694-2697. PubMed ID: 33131265
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal.
    Thein SL; Pirenne F; Fasano RM; Habibi A; Bartolucci P; Chonat S; Hendrickson JE; Stowell SR
    Haematologica; 2020 Mar; 105(3):539-544. PubMed ID: 32029505
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
    Pirenne F; Bartolucci P; Habibi A
    Transfus Clin Biol; 2017 Sep; 24(3):227-231. PubMed ID: 28669521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematologic emergencies. Management of transfusion reactions and crises in sickle cell disease.
    Dabrow MB; Wilkins JC
    Postgrad Med; 1993 Apr; 93(5):183-90. PubMed ID: 8460076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transfusion and sickle cell disease].
    Boulat C
    Transfus Clin Biol; 2013 May; 20(2):68-71. PubMed ID: 23597585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune hemolytic anemia complicating transfusion for bleeding ulcer: use of steroid therapy.
    FLEISHER PF
    J Am Osteopath Assoc; 1960 Aug; 59():994-8. PubMed ID: 13823433
    [No Abstract]   [Full Text] [Related]  

  • 34. Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France.
    Falguière C; Allali S; Khazem B; Kamdem A; Arnaud C; Belloy M; Guitton C; Odièvre MH; Pertuisel S; Dumesnil C; Guillaumat C; Garrec N; Gauthier A; Mahe P; Soussan-Banini V; Le-Carrer L; Merlin E; David A; Pellegrino B; Paillard C; Brasme JF; Lagarde M; Pirenne F; Pondarre C
    Haematologica; 2023 Mar; 108(3):889-894. PubMed ID: 36325889
    [No Abstract]   [Full Text] [Related]  

  • 35. Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement.
    Covington ML; Cone-Sullivan JK; Andrzejewski C; Lu W; Thomasson RR; O'Brien K; Brunker PAR; Stowell SR
    Transfusion; 2022 Aug; 62(8):1662-1670. PubMed ID: 35778994
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy.
    Stone EF; Avecilla ST; Wuest DL; Lomas-Francis C; Westhoff CM; Diuguid DL; Sadelain M; Boulad F; Shi PA
    Haematologica; 2021 Jan; 106(1):310-312. PubMed ID: 32817291
    [No Abstract]   [Full Text] [Related]  

  • 37. Delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Cummins D; Webb G; Shah N; Davies SC
    Postgrad Med J; 1991 Jul; 67(789):689-91. PubMed ID: 1924062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperhemolysis Syndrome in Patients With Sickle Cell Disease.
    Banks M; Shikle J
    Arch Pathol Lab Med; 2018 Nov; 142(11):1425-1427. PubMed ID: 30407854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.
    Vichinsky EP; Luban NL; Wright E; Olivieri N; Driscoll C; Pegelow CH; Adams RJ;
    Transfusion; 2001 Sep; 41(9):1086-92. PubMed ID: 11552063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Delayed hemolytic transfusion reaction in sicle cell disease patients: a new challenge for the Hemovigilance network].
    Rieux C; De Meyer E; Boudjedir K
    Transfus Clin Biol; 2015 Mar; 22(1):37-41. PubMed ID: 25441454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.